Related Experiment Video
Updated: Sep 26, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Coronary artery calcification is a risk factor for intradialytic hypotension in patients undergoing hemodialysis
Sonoo Mizuiri1, Yoshiko Nishizawa1, Toshiki Doi1,2
1Division of Nephrology, Ichiyokai Harada Hospital, Hiroshima, Japan.
Insights
Intradialytic hypotension (IDH) and high coronary artery calcification (CACS) are risk factors for mortality in hemodialysis patients. Combining IDH and high CACS significantly increases cardiovascular mortality risk.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Intradialytic hypotension (IDH) is a common complication in hemodialysis (HD) patients.
- Coronary artery calcification (CACS) is prevalent in HD patients and associated with cardiovascular risk.
Purpose of the Study:
- To investigate the association between IDH and CACS in HD patients.
- To evaluate the combined effects of IDH and CACS on all-cause and cardiovascular mortality.
Main Methods:
- Prospective study of maintenance HD patients.
- IDH defined by low systolic blood pressure or vasopressor use during HD sessions.
- CACS assessed using Agatston score at baseline.
- Mortality followed for 3 years.
Main Results:
- IDH occurred in 21.4% of patients and was associated with higher CACS.
- A CACS cutoff of 1829 predicted mortality.
- Patients with both IDH and high CACS (≥1829) had significantly lower 3-year survival from cardiovascular death (66.7%) compared to other groups.
- IDH and high CACS were independent predictors of mortality, with a synergistic effect on cardiovascular mortality.
Conclusions:
- High CACS may serve as a biomarker for IDH in HD patients.
- Both IDH and high CACS are significant risk factors for mortality in HD patients.
- A synergistic interaction exists between IDH and high CACS, increasing cardiovascular mortality risk.
Introduction:
We investigated the association between intradialytic hypotension (IDH) and coronary artery calcification and their effects on mortality in hemodialysis (HD) patients.
Methods:
Consecutive patients undergoing maintenance HD were enrolled. The study timeline included the baseline (day 1), exposure assessment (day 1-day 22), and outcome assessment (day 23-3 years) periods. IDH was defined as a nadir systolic blood pressure (SBP) of <100 mmHg or vasopressor use during at least 2 of 10 HD sessions in the exposure assessment period. The clinical data at baseline and the Agatston coronary artery calcium score (CACS) were assessed in the exposure assessment period.
Findings:
The median age and dialysis vintage were 67 years [60-75 years] and 73 months [37-138 months], respectively. IDH occurred in 37 patients (21.4%), and the CACS was higher in the IDH group than in the non-IDH group (p = 0.08). IDH was associated with CACS, diabetes mellitus, mean predialysis SBP, and mean ultrafiltration volume (p < 0.05). The cutoff CACS for mortality was 1829 (sensitivity: 69%, specificity: 77%). In all, 45 all-cause deaths and 19 cardiovascular deaths occurred over 3 years. Patients with both IDH and a CACS of ≥1829 had a lower 3-year cumulative survival from cardiovascular death (66.7%) than those with a CACS of ≥1829 (80.3%), IDH (88.5%), or neither (95.5%) (p < 0.01). IDH, a CACS of ≥1829, and IDH + CACS of ≥1829 were predictors of 3-year all-cause and cardiovascular mortality (p < 0.05). The hazard ratio for cardiovascular mortality was highest in the group with IDH + CACS ≥ 1829.
Discussion:
A high CACS may be a biomarker for IDH. Both IDH and CACS were risk factors for all-cause and cardiovascular mortality in patients undergoing HD, and there was a synergistic interaction between IDH and high CACS for cardiovascular mortality.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Hemodialysis II: Procedure and Complications
Coronary Artery Disease IV: Preventive Measures
Cardiac Catheterization I: Pre-Procedure Overview
Hemodialysis III: Nursing Management

